AAM
Arabesque Asset Management Portfolio holdings
AUM
$296M
This Quarter Return
+12.28%
1 Year Return
-15.19%
3 Year Return
+121.56%
5 Year Return
–
10 Year Return
–
AUM
$296M
AUM Growth
+$296M
(+44%)
Cap. Flow
+$71.5M
Cap. Flow
% of AUM
24.18%
Top 10 Holdings %
Top 10 Hldgs %
16.23%
Holding
144
New
31
Increased
54
Reduced
21
Closed
14
Top Buys
| 1 |
Enphase Energy
ENPH
|
$3.47M |
| 2 |
Mastercard
MA
|
$3.22M |
| 3 |
Visa
V
|
$3.19M |
| 4 |
Cisco
CSCO
|
$2.69M |
| 5 |
Eaton
ETN
|
$2.68M |
Top Sells
| 1 |
Booking.com
BKNG
|
$2.56M |
| 2 |
Costco
COST
|
$2.45M |
| 3 |
Dollar General
DG
|
$2.33M |
| 4 |
Willis Towers Watson
WTW
|
$2.12M |
| 5 |
Weyerhaeuser
WY
|
$1.91M |
Sector Composition
| 1 | Healthcare | 26.5% |
| 2 | Technology | 19.38% |
| 3 | Consumer Discretionary | 13.59% |
| 4 | Industrials | 13.52% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$210B
| $5.51M | 1.86% | 49,653 +22,132 | +80% | +$2.46M |
|
2
Linde
LIN
$224B
| $4.94M | 1.67% | 15,145 +2,381 | +19% | +$777K |
|
3
Pfizer
PFE
$141B
| $4.93M | 1.67% | 96,213 +43,810 | +84% | +$2.24M |
|
4
Eli Lilly
LLY
$657B
| $4.81M | 1.63% | 13,143 +5,211 | +66% | +$1.91M |
|
5
Broadcom
AVGO
$1.4T
| $4.79M | 1.62% | 8,559 +4,013 | +88% | +$2.24M |
|
6
AbbVie
ABBV
$372B
| $4.69M | 1.59% | 29,045 +12,883 | +80% | +$2.08M |
|
7
Trane Technologies
TT
$92.5B
| $4.69M | 1.59% | 27,908 +12,638 | +83% | +$2.12M |
|
8
Coca-Cola
KO
$297B
| $4.67M | 1.58% | 73,354 +37,412 | +104% | +$2.38M |
|
9
Union Pacific
UNP
$133B
| $4.5M | 1.52% | 21,755 +11,752 | +117% | +$2.43M |
|
10
Bristol-Myers Squibb
BMY
$96B
| $4.44M | 1.5% | 61,677 +20,212 | +49% | +$1.45M |
|
11
Texas Instruments
TXN
$184B
| $4.43M | 1.5% | 26,840 +13,196 | +97% | +$2.18M |
|
12
TJX Companies
TJX
$152B
| $4.31M | 1.46% | 54,145 +29,938 | +124% | +$2.38M |
|
13
Johnson & Johnson
JNJ
$427B
| $4.26M | 1.44% | 24,103 +10,073 | +72% | +$1.78M |
|
14
O'Reilly Automotive
ORLY
$88B
| $4.13M | 1.4% | 4,891 -218 | -4% | -$184K |
|
15
Amgen
AMGN
$155B
| $4.09M | 1.38% | 15,556 +4,547 | +41% | +$1.19M |
|
16
Abbott
ABT
$231B
| $4.07M | 1.38% | 37,035 +13,199 | +55% | +$1.45M |
|
17
AutoZone
AZO
$70.2B
| $4.01M | 1.36% | 1,628 -120 | -7% | -$296K |
|
18
Thermo Fisher Scientific
TMO
$186B
| $3.94M | 1.33% | 7,160 +3,189 | +80% | +$1.76M |
|
19
Danaher
DHR
$147B
| $3.86M | 1.31% | 14,537 +5,054 | +53% | +$1.34M |
|
20
Mondelez International
MDLZ
$79.5B
| $3.84M | 1.3% | 57,613 +22,365 | +63% | +$1.49M |
|
21
Regeneron Pharmaceuticals
REGN
$61.5B
| $3.75M | 1.27% | 5,199 +1,390 | +36% | +$1M |
|
22
Qualcomm
QCOM
$173B
| $3.57M | 1.21% | 32,437 +15,351 | +90% | +$1.69M |
|
23
Procter & Gamble
PG
$368B
| $3.56M | 1.2% | 23,494 +7,331 | +45% | +$1.11M |
|
24
Gilead Sciences
GILD
$140B
| $3.53M | 1.2% | 41,171 +4,390 | +12% | +$377K |
|
|
25
Enphase Energy
ENPH
$4.93B
| $3.47M | 1.17% | +13,084 | New | +$3.47M |
|